INS and metabolic syndrome: In the subsample (n = 80), women with the MetS revealed significantly higher fasting insulin (p = 0.02), and FAI (p = 0.03), while SHBG were significantly lower compared to their non-MetS counterparts (p = 0.0083) (Table 2).